Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03782103 · ClinicalTrials.gov registry record · Phase 3
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
A Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT03782103: Completed Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.
NCT03782103 is a Phase 3 study of Surgical Skin Preparation that has completed, run by Zurex Pharma. The registered enrollment target is 156 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03782103, a Phase 3 study of Surgical Skin Preparation, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.
Primary Outcome
A 3-log10 CFU/cm\^2 bacterial reduction on the inguinal region is considered a success.
Conditions Studied
Interventions
- DRUG ChloraPrep
- DRUG ZuraPrep Clear Solution
- DRUG ZuraPrep Vehicle
Study Locations (1)
Virginia
- Microbac Laboratories, Inc. - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2019-09-26 |
| Phase | Phase 3 |
What the finished NCT03782103 record still lists
NCT03782103 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Surgical Skin Preparation appearing as the primary indexed condition, and to 3 interventions - of which ChloraPrep is the first listed.
NCT03782103 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03782103 about?
NCT03782103 is a clinical study titled "In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)". The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.
What is the current status of trial NCT03782103?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 156 participants. The study started on 2019-01-25. Estimated completion is 2019-09-26.
What conditions does trial NCT03782103 study?
This clinical trial studies the following conditions: Surgical Skin Preparation.
What interventions are being tested in trial NCT03782103?
The interventions under investigation include: ChloraPrep (DRUG), ZuraPrep Clear Solution (DRUG), ZuraPrep Vehicle (DRUG).
Who is sponsoring clinical trial NCT03782103?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03782103 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Skin Preparation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03782103's enrollment target sits among peer trials
156 1506th of 2000 higher than 492 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI